Funding helps develop screening and validation tools for functional genomics, cell line engineering and synthetic biology
Effective extractables and leachables programmes help identify compounds present in components in direct contact with a drug product
Expansion a result of continued growth of US supplements business and anticipated expansion of US animal sports business
LGC expands its supply chain assurance offering, creating a new business unit within its Standards division to focus on this growing market
LGC's NMI team instrumental in two-year process
PSI products complement existing genomics offering
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.